A Potential Drug Target or Biomarker for Translocase of Inner Mitochondrial Membrane 23 Homolog B (Yeast)

Target Name: Translocase of inner mitochondrial membrane 23 homolog B (yeast), transcript variant X1

NCBI ID: G653252

Translocase of inner mitochondrial membrane 23 homolog B (yeast), transcript variant X1

A Potential Drug Target or Biomarker for Translocase of Inner Mitochondrial Membrane 23 Homolog B (Yeast)

Mitochondria are dynamic organelles that play a crucial role in the regulation of cellular processes, including energy metabolism, signaling pathways, and stress response. Mitochondrial dysfunction has been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. The protein Translocase of Inner Mitochondrial Membrane 23 Homolog B (Yeast) (TIM-23) is a key regulator of mitochondrial function and has been extensively studied in the context of various diseases. In this article, we will explore the potential drug target or biomarker properties of TIM-23, focusing on the transcript variant X1 (long intergenic non-protein coding RNA 843).

Translocase of Inner Mitochondrial Membrane 23 Homolog B (Yeast)

TIM-23 is a member of the TIM gene family, which includes also the protein TIM-3 and the RNA molecule, TIM-R1. TIM-23 is a 23-kDa protein that is localized to the inner mitochondrial membrane and plays a critical role in the regulation of mitochondrial dynamics, including the dynamics of mitochondrial fission and fusion.

TIM-23 functions as a G protein-coupled receptor (GPCR), which allows it to interact with various signaling molecules. One of the well-documented signaling pathways involving TIM-23 is the regulation of mitochondrial fusion and fission. TIM-23 has been shown to play a role in the regulation of mitochondrial fusion and fission by interacting with the protein p23, which is a key regulator of mitochondrial fission.

In addition to its role in regulating mitochondrial fusion and fission, TIM-23 has also been shown to be involved in the regulation of mitochondrial dynamics and the dynamics of mitochondrial organelles, such as the mitochondrial outer membrane and the mitochondrial inner membrane.

Transcript variant X1 (long intergenic non-protein coding RNA 843)

Transcript variant X1 (TX1) is a long non-protein-coding RNA molecule that is derived from the coding region of the TIM-23 gene. TX1 has been identified by bioinformatics analysis and is shown to have a putative RNA binding domain and to be expressed in various tissues, including the brain, heart, and liver.

X1 has been shown to play a role in regulating gene expression in various organisms, including yeast. For example, studies have shown that X1 can interact with the protein Osm4, which is a key regulator of the unfolded state of RNA molecules. Osm4 is known to play a role in the regulation of various cellular processes, including cell growth, differentiation, and stress response.

In addition to its role in regulating gene expression, TX1 has also been shown to be involved in the regulation of cellular processes, including the regulation of mitochondrial dynamics and the regulation of cellular signaling pathways.

Potential Drug Target or Biomarker

The potential drug target or biomarker properties of TIM-23 and TX1 make them interesting targets for drug development. TIM-23 has been shown to play a role in the regulation of mitochondrial fusion and fission, which are important processes that are involved in the development of certain diseases, such as cancer. Additionally, TIM-23 has been shown to be involved in the regulation of cellular signaling pathways, which are important for the regulation of cellular processes that are involved in the development of various diseases, including cancer.

TX1 has been shown to play a role in regulating gene expression in various organisms, including yeast. The regulation of gene expression by TX1 is important for the regulation of cellular processes, including

Protein Name: Translocase Of Inner Mitochondrial Membrane 23 Homolog B (yeast), Transcript Variant X1

The "Translocase of inner mitochondrial membrane 23 homolog B (yeast), transcript variant X1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Translocase of inner mitochondrial membrane 23 homolog B (yeast), transcript variant X1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets